Published in

Springer Nature [academic journals on nature.com], British Journal of Cancer, 7(119), p. 793-800, 2018

DOI: 10.1038/s41416-018-0179-6

Links

Tools

Export citation

Search in Google Scholar

25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial.

Journal article published in 2018 by Astrid Lipplaa, Ricardo Fernandes, Andrea Marshall, Paul C. Lorigan, Janet Dunn, Kevin A. Myers, Emily Barker, Julia Newton-Bishop ORCID, Mark R. Middleton, Pippa G. Corrie
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Studies evaluating a relationship of vitamin D in patients with primary melanoma have consistently identified an inverse correlation with Breslow thickness, but an inconsistent impact on survival. Vitamin D in later stages of melanoma has been less studied.